4
Otolaryngology-Head and Neck Surgery, Vol 143, No 1S1, July 2010
support to a Guideline Development Group (health professionals and service users). Working with guideline developers from the National Collaborating Centre for Mental Health, NICE has provided hands-on assistance and training to the Turkish team and the Guideline Development Group. The intention is to improve rates of caesarean section and to increase the capacity of the MoH to establish a guidance development program. LEARNING OBJECTIVES (TRAINING GOALS): 1. Understand the technical, linguistic, and cultural challenges encountered when working across borders to produce clinical guidance. 2. Identify the different ways health systems are influenced by local issues and find solutions to help improve guideline development and implementation. 3. Examine how, in some circumstances, clinical guideline development might evolve from producing evidencebased textbooks to flexible evidence-based encyclopedias. DESCRIPTION: This highly interactive workshop will be split into three parts: 1) An introduction to NICE International and the project with Turkey, highlighting, from NICE’s perspective, the technical, linguistic, and cultural challenges, and the fresh perspectives it has brought for us; 2) How are different health care systems influenced by local issues? A discussion of how these issues impact on guideline development and implementation; 3) Evidence-based textbook or evidencebased encyclopedia? A discussion of how guideline development might become more focused around answering a given set of clinical questions rather than attempting to evaluate a certain clinical condition. TARGET AUDIENCE(S): 1. Evidence synthesizer, developer of systematic reviews or meta-analyses 2. Guideline developer 3. Guideline implementer 4. Developer of guideline-based products
W7– Developing dynamic tobacco control guidelines in Canada Peter Selby, MBBS (Centre for Addiction and Mental Health - CAN-ADAPTT, Toronto, Ontario, Canada); Jess Rogers, BA (Centre for Effective Practice, Toronto, Ontario, Canada); Katie Hunter, MSc (Centre for Addiction and Mental Health CAN-ADAPTT, Toronto, Ontario, Canada); Tamar Meyer, MA (Centre for Addiction and Mental Health - CAN-ADAPTT, Toronto, Ontario, Canada); Janet Ngo, MA (Centre for Addiction and Mental Health CAN-ADAPTT, Toronto, Ontario, Canada) PRIMARY TRACK: Guideline development SECONDARY TRACK: Guideline development methods
BACKGROUND (INTRODUCTION): Health care practitioners do not consistently implement clinical practice guidelines (CPGs) for tobacco control. Barriers to use can be attributed to the traditional research-driven development process. CAN-ADAPTT (Canadian Action Network for the Advancement, Dissemination and Adoption of Practice-informed Tobacco Treatment) aims to overcome this in developing Canada’s first CPGs for tobacco control. By facilitating research and knowledge exchange among practitioners, this non-traditional guideline development process will be dynamic; reflecting an evolving evidence base, practice environment, client/patient need, and treatment opportunities. LEARNING OBJECTIVES (TRAINING GOALS): 1. Learn the process used to develop Canadian clinical practice guidelines (CPGs) for tobacco control. 2. Understand the benefits of a dynamic guideline development process using online features. 3. Understand challenges to guideline development using a practice-based network (PRBN) and discuss ways to overcome them. DESCRIPTION: Participants will be introduced to the process CAN-ADAPTT used to develop a national set of clinical practice guidelines (CPGs). This involved systematically searching and compiling existing guidelines on tobacco control followed by using the AGREE instrument to determine the highest-scoring CPGs. User feedback was then incorporated through review cycles, creating guidelines applicable to multiple contexts and responsive to the needs of diverse target users. The dynamic nature of these guidelines is facilitated through the creation of a Practice-Based Research Network (PBRN) where users define and frame research questions informed by their practices. Seed grants were offered for the pursuit of research in treating tobacco; an online platform was created to ensure the guidelines are reflective of the real needs of its users; and a discussion board encourages input from practitioners and knowledge exchange among PBRN members. Interactive discussion will focus on engagement of users throughout the guideline development and dissemination process. TARGET AUDIENCE(S): 1. Clinical researcher 2. Evidence synthesizer, developer of systematic reviews or meta-analyses 3. Guideline developer 4. Developer of guideline-based products 5. Health care policy analyst/policy-maker 6. Allied health professionals 7. Nurses
W8– Applicability of clinical practice guidelines to patients with comorbid conditions: how to address comorbidity in guidelines? Marjolein Lugtenberg, MS (Tilburg University, TRANZO, Tilburg, Netherlands);